{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:32:36Z","timestamp":1788636756468,"version":"build-2803163510"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kraeftens Bekaempelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.radonc.2025.110950","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T19:15:36Z","timestamp":1747941336000},"page":"110950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Recommendations for radiotherapy quality assurance in clinical trials"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7547-5455","authenticated-orcid":false,"given":"Camilla Panduro","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-669X","authenticated-orcid":false,"given":"Eva","family":"Sams\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7356-2096","authenticated-orcid":false,"given":"Birgitte Vrou","family":"Offersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1895-733X","authenticated-orcid":false,"given":"Ebbe Laugaard","family":"Lorenzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3363-3256","authenticated-orcid":false,"given":"Gitte","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5759-5349","authenticated-orcid":false,"given":"Hanna Rahbek","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-5463","authenticated-orcid":false,"given":"Henrik Dahl","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8877-1218","authenticated-orcid":false,"given":"Ivan Richter","family":"Vogelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3705-5390","authenticated-orcid":false,"given":"Jesper Folsted","family":"Kallehauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7418-5832","authenticated-orcid":false,"given":"Ludvig Paul","family":"Muren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4353-135X","authenticated-orcid":false,"given":"Mads","family":"Brincker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1069-5999","authenticated-orcid":false,"given":"Mette van Overeem","family":"Felter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1538-4361","authenticated-orcid":false,"given":"Rikke Hedegaard","family":"Dahlrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9435-8143","authenticated-orcid":false,"given":"Steffen Bjerre","family":"Hokland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-1561","authenticated-orcid":false,"given":"Tine","family":"Schytte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6566-5367","authenticated-orcid":false,"given":"Birgitte Mayland","family":"Havelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-1204","authenticated-orcid":false,"given":"Britta","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9910-515X","authenticated-orcid":false,"given":"Ditte Sloth","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6851-2086","authenticated-orcid":false,"given":"Eva","family":"Serup-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2364-965X","authenticated-orcid":false,"given":"Kenneth","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Leg\u00e5rd","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-162X","authenticated-orcid":false,"given":"Mirjana","family":"Josipovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7511-989X","authenticated-orcid":false,"given":"Simon Long","family":"Krogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-095X","authenticated-orcid":false,"given":"Sl\u00e1vka","family":"Lukacova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-0421","authenticated-orcid":false,"given":"Lone","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-6069","authenticated-orcid":false,"given":"Christian R\u00f8nn","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110950_b0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2023.08.014","article-title":"Analysis of radiation therapy quality assurance in NRG oncology RTOG 0848","volume":"118","author":"Tchelebi","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110950_b0010","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2014.09.003","article-title":"Quality assurance standards drive improvements in the profile of radiation therapy departments participating in trials of the EORTC Radiation Oncology Group","volume":"112","author":"Grant","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/02841868409136037","article-title":"Dosimetric precision requirements in radiation therapy","volume":"23","author":"Brahme","year":"1984","journal-title":"Acta Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2007.07.001","article-title":"Quality assurance of dosimetry and the impact on sample size in randomised clinical trials","volume":"86","author":"Pettersen","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0025","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0030","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1016\/S1470-2045(23)00625-3","article-title":"Radiotherapy trial quality assurance processes: a systematic review","volume":"25","author":"Brooks","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2022.04.029","article-title":"Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres","volume":"172","author":"Hoffmann","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/acm2.12384","article-title":"Executive summary of AAPM Report Task Group 113: Guidance for the physics aspects of clinical trials","volume":"19","author":"Moran","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.110950_b0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmp.2017.04.003","article-title":"The role of dosimetry audit in lung SBRT multi-centre clinical trials","volume":"44","author":"Clark","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2025.110950_b0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2021.07.017","article-title":"Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial","volume":"163","author":"Gkika","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijrobp.2020.04.042","article-title":"Central review of radiation therapy planning among patients with breast-conserving surgery: results from a quality assurance process integrated into the INSEMA trial","volume":"107","author":"Hildebrandt","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110950_b0060","doi-asserted-by":"crossref","first-page":"311 -","DOI":"10.3389\/fonc.2013.00311","article-title":"Quality assurance for clinical trials","volume":"3","author":"Ibbott","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109494","article-title":"Prioritising clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison","volume":"182","author":"Taylor","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110060","article-title":"Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)","volume":"195","author":"Kaidar-Person","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: Defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2025.110950_b0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2021.11.018","article-title":"The radiotherapy quality assurance gap among phase III cancer clinical trials","volume":"166","author":"Corrigan","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/tct.12776","article-title":"How to\u2026write a good research question","volume":"15","author":"Mattick","year":"2018","journal-title":"Clin Teach"},{"key":"10.1016\/j.radonc.2025.110950_b0090","article-title":"Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomised Phase III Trial:The DBCG HYPO","author":"Offersen","year":"2020","journal-title":"Trial"},{"key":"10.1016\/j.radonc.2025.110950_b0095","doi-asserted-by":"crossref","unstructured":"Tine Schytte CK, Ane Appelt, Azza Khalil, Carsten Brink, Christina Maria Lutz, Ditte Slot, et al. The NARLAL II trial: First results on loco-regional control in stage 3 NSCLC. ESTRO 2024 - Abstract book. 2024.","DOI":"10.1016\/S0167-8140(24)03438-8"},{"key":"10.1016\/j.radonc.2025.110950_b0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2017.06.022","article-title":"Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomised, multi-centre phase-III study","volume":"124","author":"M\u00f8ller","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0105","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/jama.2017.18556","article-title":"Guidelines for the content of statistical analysis plans in clinical trials","volume":"318","author":"Gamble","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2025.110950_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2023.101100","article-title":"A template for the authoring of statistical analysis plans","volume":"34","author":"Stevens","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.radonc.2025.110950_b0115","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.jid.2018.06.165","article-title":"Research techniques made simple: sample sizeestimation and power calculation","volume":"138","author":"Schmidt","year":"2018","journal-title":"J, Invest Dermatol"},{"key":"10.1016\/j.radonc.2025.110950_b0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.11613\/BM.2021.010502","article-title":"Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies","volume":"31","author":"Serdar","year":"2021","journal-title":"Biochemia Medica"},{"key":"10.1016\/j.radonc.2025.110950_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.106215","article-title":"Sample size re-estimation for pivotal clinical trials","volume":"102","author":"Liu","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.radonc.2025.110950_b0130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jnci\/djt001","article-title":"Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials","volume":"105","author":"Ohri","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2025.110950_b0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/2229-3485.100663","article-title":"Protocol deviation and violation","volume":"3","author":"Bhatt","year":"2012","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.radonc.2025.110950_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109549","article-title":"Radiotherapy quality assurance in paediatric clinical trials: first report from six QUARTET-affiliated trials","volume":"182","author":"Kelly","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0145","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3109\/0284186X.2015.1063780","article-title":"Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomised trial","volume":"54","author":"Hansen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/2229-3485.184817","article-title":"Assessment and classification of protocol deviations","volume":"7","author":"Ghooi","year":"2016","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.radonc.2025.110950_b0155","unstructured":"NHS. The NHS Cancer Plan. 2000."},{"key":"10.1016\/j.radonc.2025.110950_b0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000163058","article-title":"Impact of Tumor Board Recommendations on Treatment Outcome for Locally Advanced Head and Neck Cancer","volume":"75","author":"Nguyen","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.radonc.2025.110950_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcts.2010.01.051","article-title":"The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer","volume":"38","author":"Freeman","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.radonc.2025.110950_b0170","first-page":"1887","article-title":"Multidisciplinary team intervention associated with improved survival for patients with colorectal adenocarcinoma with liver or lung metastasis","volume":"8","author":"Chen","year":"2018","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.radonc.2025.110950_b0175","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healthpol.2014.09.006","article-title":"Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes","volume":"119","author":"Prades","year":"2015","journal-title":"Health Policy"},{"key":"10.1016\/j.radonc.2025.110950_b0180","unstructured":"Sundhedsstyrelsen. Kr\u00e6ftplan II. 2005."},{"key":"10.1016\/j.radonc.2025.110950_b0185","article-title":"Multidisciplin\u00e6r kr\u00e6ftbehandling \u2013 en vejledning til MDT-konferencen","author":"Dmcg","year":"2016","journal-title":"Danske Multidisciplin\u00e6re Cancer Grupper"},{"key":"10.1016\/j.radonc.2025.110950_b0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/0284186X.2019.1685128","article-title":"IAEA methodology for on-site end-to-end IMRT\/VMAT audits: an international pilot study","volume":"59","author":"Kazantsev","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0195","unstructured":"Ibbott GS, Thwaites DI, Iop. Audits for advanced treatment dosimetry. 1 ed. BRISTOL: Iop Publishing Ltd. p. 12002-11."},{"key":"10.1016\/j.radonc.2025.110950_b0200","article-title":"Interobserver variation in organs at risk contouring in head and neck cancer according to the DAHANCA guidelines","volume":"110337","author":"Nielsen","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.radonc.2022.04.005","article-title":"Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours","volume":"171","author":"Hoffmann","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110372","article-title":"Quality assessment of radiotherapy in the prospective randomised SENOMAC trial","volume":"197","author":"Alkner","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0215","doi-asserted-by":"crossref","unstructured":"Hansen CR, Johansen J, Kristensen CA, Smulders B, Andersen LJ, Sams\u00f8e E et al. Radiotherapy quality assurance of patients with squamous cell carcinoma of the head and neck included in the DAHANCA 19 randomised phase III trial. Radiother Oncol. 2025;Submitted.","DOI":"10.1016\/j.radonc.2025.111096"},{"key":"10.1016\/j.radonc.2025.110950_b0220","article-title":"Quality assurance of internal mammary node irradiation in the DBCG IMN2 study","volume":"202","author":"Refsgaard","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0225","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.seminhematol.2008.04.010","article-title":"Perfect study, poor evidence: interpretation of biases preceding study design","volume":"45","author":"Ioannidis","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1016\/j.radonc.2025.110950_b0230","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.290.12.1624","article-title":"Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy","volume":"290","author":"Tunis","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2025.110950_b0235","unstructured":"ICMJE. Defining the Role of Authors and Contributors."},{"key":"10.1016\/j.radonc.2025.110950_b0240","first-page":"118","article-title":"Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial","volume":"28","author":"Thomsen","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.meddos.2015.08.001","article-title":"Residual position errors of lymph node surrogates in breast cancer adjuvant radiotherapy: Comparison of two arm fixation devices and the effect of arm position correction","volume":"41","author":"Kapanen","year":"2016","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2025.110950_b0250","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/0284186X.2018.1554261","article-title":"The value of a bladder-filling protocol for patients with prostate cancer who receive post-operative radiation: results from a prospective clinical trial","volume":"58","author":"Braide","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0255","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1097\/JTO.0b013e3182307ec2","article-title":"Respiratory Gating Techniques for Optimisation of Lung Cancer Radiotherapy","volume":"6","author":"Giraud","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0260","first-page":"1188","article-title":"Consensus recommendations for a standardised Brain Tumor Imaging Protocol in clinical trials","volume":"17","author":"Ellingson","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0265","doi-asserted-by":"crossref","unstructured":"Brock KK, Mutic S, McNutt TR, Li H, Kessler ML. Use of image registration and fusion algorithms and techniques in radiotherapy: Report of the AAPM Radiation Therapy Committee Task Group No. 132: Report. Medical physics (Lancaster). 2017;44:e43-e76.","DOI":"10.1002\/mp.12256"},{"key":"10.1016\/j.radonc.2025.110950_b0270","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1080\/0284186X.2023.2266560","article-title":"Geometric distortions in clinical MRI sequences for radiotherapy: insights gained from a multicenter investigation","volume":"62","author":"Hasler","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0275","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210001","article-title":"Clinical use, challenges, and barriers to implementation of deformable image registration in radiotherapy \u2013 the need for guidance and QA tools","volume":"94","author":"Hussein","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2025.110950_b0280","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semradonc.2019.02.002","article-title":"Deformable Registration for Dose Accumulation","volume":"29","author":"Chetty","year":"2019","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0285","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ad0d8a","article-title":"Review and recommendations on deformable image registration uncertainties for radiotherapy applications","volume":"68","author":"Nenoff","year":"2023","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.110950_b0290","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2017.12.013","article-title":"American Association of Physicists in Medicine Task Group 263: Standardising Nomenclatures in Radiation Oncology","volume":"100","author":"Mayo","year":"2018","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.radonc.2025.110950_b0295","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ijrobp.2011.09.054","article-title":"Standardising Naming Conventions in Radiation Oncology","volume":"83","author":"Santanam","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110950_b0300","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/0284186X.2023.2270143","article-title":"A national repository of complete radiotherapy plans: design, Results, and experiences","volume":"62","author":"Krogh","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0305","unstructured":"Westberg J, Krogh S, Brink C, Vogelius IR, Iop. A DICOM based radiotherapy plan database for research collaboration and reporting. 1 ed. BRISTOL: Iop Publishing Ltd. p. 12100-5."},{"key":"10.1016\/j.radonc.2025.110950_b0310","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.radonc.2014.03.019","article-title":"Correlation of contouring variation with modeled outcome for conformal non-small cell lung cancer radiotherapy","volume":"112","author":"Jameson","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0315","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2022.11.021","article-title":"Assessing Interobserver Variability in the Delineation of Structures in Radiation Oncology: A Systematic Review","volume":"115","author":"Guzene","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110950_b0320","article-title":"Imaging for Target Delineation in Head and Neck Cancer Radiotherapy","author":"Jensen","year":"2020","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.radonc.2025.110950_b0325","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2020.05.038","article-title":"Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines","volume":"150","author":"Mir","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0330","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-016-0678-7","article-title":"Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications","volume":"11","author":"Mohamed","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0335","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1200\/JCO.2015.61.2994","article-title":"Advances in Radiotherapy for Head and Neck Cancer","volume":"33","author":"Gregoire","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0340","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2018.06.032","article-title":"The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT)","volume":"130","author":"Navran","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0345","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2020.06.015","article-title":"Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups","volume":"150","author":"Milo","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0350","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/0284186X.2021.1975813","article-title":"A national study on the inter-observer variability in the delineation of organs at risk in the brain","volume":"60","author":"Lorenzen","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0355","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1080\/0284186X.2023.2256958","article-title":"Consistency in contouring of organs at risk by artificial intelligence vs oncologists in head and neck cancer patients","volume":"62","author":"Nielsen","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0360","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.radonc.2017.03.011","article-title":"Quality assessment of delineation and dose planning of early breast cancer patients included in the randomised Skagen Trial 1","volume":"123","author":"Francolini","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0365","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2020.09.038","article-title":"What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans","volume":"153","author":"Hernandez","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0370","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180270","article-title":"Automation in intensity modulated radiotherapy treatment planning-a review of recent innovations","volume":"91","author":"Hussein","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2025.110950_b0375","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.oraloncology.2018.09.001","article-title":"IMRT - Biomarkers for dose escalation, dose de-escalation and personalised medicine in radiotherapy for head and neck cancer","volume":"86","author":"Andreassen","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2017.06.003","article-title":"European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer","volume":"124","author":"De Ruysscher","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0385","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2025.110950_b0390","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s12094-020-02540-2","article-title":"Recommended procedures and responsibilities for radiosurgery (SRS) and extracranial stereotactic body radiotherapy (SBRT): report of the SEOR in collaboration with the SEFM","volume":"23","author":"Conde-Moreno","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0395","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2021.03.006","article-title":"Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximise consistency","volume":"159","author":"Kry","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0400","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1088\/0031-9155\/51\/22\/005","article-title":"Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations","volume":"51","author":"Kn\u00f6\u00f6s","year":"2006","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.110950_b0405","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/0284186X.2011.629209","article-title":"Clinical validation of the Acuros XB photon dose calculation algorithm, a grid-based Boltzmann equation solver","volume":"51","author":"Hoffmann","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0410","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/0284186X.2019.1654129","article-title":"NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy","volume":"58","author":"Hansen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109527","article-title":"Applicability and usage of dose mapping\/accumulation in radiotherapy","volume":"182","author":"Murr","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0420","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0425","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.radonc.2019.12.009","article-title":"Quantifying the dose accumulation uncertainty after deformable image registration in head-and-neck radiotherapy","volume":"143","author":"Lowther","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0430","first-page":"4197","article-title":"Task Group 142 report: Quality assurance of medical accelerators","volume":"36","author":"Klein","year":"2009","journal-title":"Med Phys (Lancaster)"},{"key":"10.1016\/j.radonc.2025.110950_b0435","doi-asserted-by":"crossref","unstructured":"Miften M, Olch A, Mihailidis D, Moran J, Pawlicki T, Molineu A, et al. Tolerance limits and methodologies for IMRT measurement\u2010based verification QA: Recommendations of AAPM Task Group No. 218. Medical physics (Lancaster). 2018;45:e53-e83.","DOI":"10.1002\/mp.12810"},{"key":"10.1016\/j.radonc.2025.110950_b0440","first-page":"e830","article-title":"AAPM Task Group 198 Report: An implementation guide for TG 142 quality assurance of medical accelerators","volume":"48","author":"Hanley","year":"2021","journal-title":"Medical physics (Lancaster)"},{"key":"10.1016\/j.radonc.2025.110950_b0445","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.radonc.2015.06.004","article-title":"A comprehensive evaluation of treatment accuracy, including end-to-end tests and clinical data, applied to intracranial stereotactic radiotherapy","volume":"116","author":"Seravalli","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0450","first-page":"e865","article-title":"AAPM Task Group Report 307: Use of EPIDs for Patient\u2010Specific IMRT and VMAT QA","volume":"50","author":"Dogan","year":"2023","journal-title":"Medical physics (Lancaster)"},{"key":"10.1016\/j.radonc.2025.110950_b0455","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.meddos.2022.02.002","article-title":"A novel end-to-end test for combined dosimetric and geometric treatment verification using a 3D-printed phantom","volume":"47","author":"Mertens","year":"2022","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2025.110950_b0460","doi-asserted-by":"crossref","first-page":"N297","DOI":"10.1088\/0031-9155\/47\/23\/401","article-title":"When should systematic patient positioning errors in radiotherapy be corrected?","volume":"47","author":"Bortfeld","year":"2002","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.110950_b0465","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijrobp.2018.07.2006","article-title":"Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial","volume":"102","author":"de Crevoisier","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110950_b0470","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2015.06.009","article-title":"Anatomical landmarks accurately determine interfractional lymph node shifts during radiotherapy of lung cancer patients","volume":"116","author":"Hoffmann","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0475","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3109\/0284186X.2015.1062914","article-title":"A learning programme qualifying radiation therapists to manage daily online adaptive radiotherapy","volume":"54","author":"Boejen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0480","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0485","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.adro.2020.03.006","article-title":"The Impact of COVID-19 on Radiation Oncology Clinics and Patients With Cancer in the United States","volume":"5","author":"Rivera","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0490","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.clon.2018.08.001","article-title":"Adaptive Radiotherapy Enabled by MRI Guidance","volume":"30","author":"Hunt","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2025.110950_b0495","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2020.10.021","article-title":"Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology","volume":"109","author":"Glide-Hurst","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110950_b0500","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.canrad.2020.04.007","article-title":"Multimodal imaging in radiotherapy: Focus on adaptive therapy and quality control","volume":"24","author":"Talbot","year":"2020","journal-title":"Cancer radioth\u00e9rapie"},{"key":"10.1016\/j.radonc.2025.110950_b0505","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.22.00451","article-title":"Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomised Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial","volume":"40","author":"Offersen","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0510","article-title":"Danish and Swedish National Data Collections for Cancer - Solutions for Radiotherapy","volume":"37","author":"Olsson","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2025.110950_b0515","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/0284186X.2017.1406140","article-title":"DBCG hypo trial validation of radiotherapy parameters from a national data bank versus manual reporting","volume":"57","author":"Brink","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0520","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and Reliability of the US National Cancer Institute\u2019s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0525","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. U.S. Department of Health and Human Services; 2017."},{"key":"10.1016\/j.radonc.2025.110950_b0530","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/jjco\/hyt028","article-title":"Evaluation of interobserver and interscale agreement in assessing late bowel toxicity after pelvic radiation in patients with carcinoma of the cervix","volume":"43","author":"Chinnachamy","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0535","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomised trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0540","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2025.110950_b0545","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localised prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110950_b0550","first-page":"228","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"2009","author":"Eisenhauer","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2025.110950_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110284","article-title":"Comparison of 3-year local control using DAHANCA radiotherapy guidelines before and after implementation of five millimetres geometrical GTV to high-dose CTV margin","volume":"196","author":"Zukauskaite","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0560","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2017.11.024","article-title":"Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins","volume":"126","author":"Zukauskaite","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0565","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.3390\/app12073223","article-title":"Recent Applications of Artificial Intelligence in Radiotherapy: Where We Are and Beyond","volume":"12","author":"Santoro","year":"2022","journal-title":"Appl Sci"},{"key":"10.1016\/j.radonc.2025.110950_b0570","article-title":"Multicentre prospective risk analysis of a fully automated radiotherapy workflow","volume":"34","author":"De Kerf","year":"2025","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110950_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110042","article-title":"Recommendation on the technical and dosimetric data to be included in stereotactic body radiation therapy clinical trial publications based on a systematic review","volume":"190","author":"Hardcastle","year":"2024","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025044548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025044548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:22:12Z","timestamp":1761128532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025044548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":115,"alternative-id":["S0167814025044548"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110950","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for radiotherapy quality assurance in clinical trials","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110950"}}